Citizens lowered the firm’s price target on Bowhead Specialty (BOW) to $35 from $38 and keeps an Outperform rating on the shares. The firm expects Q1 results to be highlighted by lighter-than-typical catastrophe losses, modest MTM negative impact on book values and ongoing potential for continued issues around casualty loss reserves. With that said, Citizens believes investor focus will be zeroed in on the pricing environment as weakness in certain areas, notably property, has spooked the market broadly and is now spreading to an increasing number of lines across the industry.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty price target lowered to $31 from $36 at Keefe Bruyette
- Bowhead Specialty price target lowered to $25 from $27 at Morgan Stanley
- Bowhead Specialty Earnings Call Highlights Profitable Growth
- Bowhead Specialty price target lowered to $27 from $29 at Morgan Stanley
- Bowhead Specialty price target lowered to $30 from $33 at RBC Capital
